Status:
WITHDRAWN
Dilute Bleach Compresses for Radiation Dermatitis
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Radiation Dermatitis
Eligibility:
All Genders
12-25 years
Phase:
EARLY_PHASE1
Brief Summary
This study is looking at the safety of applying dilute bleach compresses to patients receiving radiation therapy and the impact of these dilute bleach compresses on the frequency and severity of skin ...
Detailed Description
This is a planned open-label prospective clinical trial to determine the safety of applying dilute bleach compresses to pediatric patients being treated for rhabdomyosarcoma and other soft tissue and ...
Eligibility Criteria
Inclusion
- Diagnosed with a rhabdomyosarcoma or other sarcoma requiring RT
- 12 to 25 years of age
- Scheduled for a RT planning session (CT simulation)
- Have a scheduled RT start date within 1 to 2 weeks from the CT simulation
- Will be receiving doses of radiotherapy greater than at least 36 Gy
- Subjects may participate in other studies, including therapeutic trials.
- Ability to comply with at-home dilute Di-Dak-Sol compresses for final week of dilute Di-Dak-Sol compresses following radiation treatment.
- Ability to understand and/or the willingness of their parent or legally authorized representative to sign a written informed consent document.
Exclusion
- Patients who are pregnant, which may result in discontinuation of RT
- Presence of inflammatory skin lesions in the radiation field that could interfere with assessment
Key Trial Info
Start Date :
June 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04851522
Start Date
June 9 2021
End Date
April 1 2023
Last Update
February 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.